Advertising for over-the-counter antacids : final staff report and recommendations

LDR 01322nam a22003611a 4500
001 001838996
003 MiAaHDL
005 20221206000000.0
006 m d
007 cr bn ---auaua
008 900402s1983 dcua b f000 0 eng c
010 ⊔ ⊔ ‡a83602871
035 ⊔ ⊔ ‡a(MiU)990018389960106381
035 ⊔ ⊔ ‡asdr-miu.990018389960106381
035 ⊔ ⊔ ‡asdr-uiuc581478
035 ⊔ ⊔ ‡asdr-ucr.b19265360
035 ⊔ ⊔ ‡z(MiU)MIU01000000000000001838996-goog
035 ⊔ ⊔ ‡a(OCoLC)9965658
035 ⊔ ⊔ ‡a(RLIN)MIUG90-B15343
035 ⊔ ⊔ ‡z(MiU)Aleph001838996
040 ⊔ ⊔ ‡aDGPO/DLC ‡cDLC ‡dDLC
043 ⊔ ⊔ ‡an-us---
050 0 0 ‡aRM365 ‡b.U55 1983
082 0 0 ‡a363.1/94 ‡219
086 0 ⊔ ‡aFT 1.2:Ov 2/2
110 1 ⊔ ‡aUnited States. ‡bFederal Trade Commission. ‡bBureau of Consumer Protection.
245 1 0 ‡aAdvertising for over-the-counter antacids : ‡bfinal staff report and recommendations.
260 ⊔ ⊔ ‡a[Washington, D.C.] : ‡bFederal Trade Commission, Bureau of Consumer Protection, ‡c[1983]
300 ⊔ ⊔ ‡a1 v. (various pagings) : ‡bill. ; ‡c28 cm.
500 ⊔ ⊔ ‡aItem 535
500 ⊔ ⊔ ‡a"August 1983."
500 ⊔ ⊔ ‡aCover title.
504 ⊔ ⊔ ‡aIncludes bibliographical references.
538 ⊔ ⊔ ‡aMode of access: Internet.
650 ⊔ 0 ‡aDrugs, Nonprescription ‡xLabeling ‡zUnited States.
650 ⊔ 0 ‡aAdvertising ‡xDrugs ‡xMoral and ethical aspects.
650 ⊔ 0 ‡aAntacids ‡xSide effects.
650 ⊔ 0 ‡aAntacids ‡xLabeling ‡zUnited States.
899 ⊔ ⊔ ‡a39015016940978
CID ⊔ ⊔ ‡a001838996
DAT 0 ⊔ ‡a19900402000000.0 ‡b20221206000000.0
DAT 1 ⊔ ‡a20221210140713.0 ‡b2023-11-28T18:40:30Z
CAT ⊔ ⊔ ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-008
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-miu.990018389960106381 ‡aMiU ‡bSDR ‡cMIU ‡f001838996 ‡pmdp.39015016940978 ‡sMIU ‡1990018389960106381
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20231128 ‡sgoogle ‡umdp.39015016940978 ‡y1983 ‡rpd ‡qbib ‡tUS fed doc
974 ⊔ ⊔ ‡bUIU ‡cUIUC ‡d20230313 ‡sgoogle ‡uuiug.30112101050315 ‡y1983 ‡rpd ‡qbib ‡tUS fed doc
974 ⊔ ⊔ ‡bUC ‡cUCR ‡d20240625 ‡sgoogle ‡uuc1.31210012723217 ‡y1983 ‡rpd ‡qbib ‡tUS fed doc